跳至主要内容
临床试验/JPRN-UMIN000050332
JPRN-UMIN000050332
尚未招募
未知

Effectiveness of smartphone application "Fukusuppo App" to support head and neck cancer patients in the management of toxicities associated with immnue checkpoint inhibitor: a prospective observation study - Fukusuppo study

ational Cancer Center Hospital East0 个研究点目标入组 68 人2023年3月6日

概览

阶段
未知
干预措施
未指定
疾病 / 适应症
Patients with head and neck cancer who are scheduled to be treated with ICIs are eligible
发起方
ational Cancer Center Hospital East
入组人数
68
状态
尚未招募
最后更新
2年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2023年3月6日
结束日期
2024年8月31日
最后更新
2年前
研究类型
Observational
性别
All

研究者

发起方
ational Cancer Center Hospital East

入排标准

入选标准

  • 未提供

排除标准

  • 1\) The primary site of tumor is thyroid. 2\) Patient has a history of immune checkpoint inhibitors including other types of cancer. 3\) Patient is planned to be treated with both immune checkpoint inhibitors and chemotherapy. 4\) The patient's physician determines that the patient is not suitable to participate in this study.

结局指标

主要结局

未指定

相似试验